Search results for "Diabetes"
RSV vaccines new tool for physicians
The CDC's Advisory Committee on Immunization Practices recommended in June that adults ages 60 years and older may receive a single dose of an RSV vaccine, using shared clinical decision making.
https://acpinternist.org/archives/2023/10/rsv-vaccines-new-tool-for-physicians.htm
1 Oct 2023
Higher aspirin dose no more effective for CV prevention in high-risk patients with diabetes
A subgroup analysis of a randomized trial found that patients with diabetes and atherosclerotic cardiovascular disease had similar outcomes whether they took 81 mg or 325 mg of aspirin daily.
https://acpinternist.org/weekly/archives/2023/09/26/2.htm
26 Sep 2023
Almost 4 in 10 with type 1 diabetes were diagnosed in adulthood
Peak diagnosis age was approximately 15 years, and the median age of diagnosis was 24 years, but 37% of adults with type 1 diabetes reported having been diagnosed after age 30 years in a recent study.
https://acpinternist.org/weekly/archives/2023/09/26/1.htm
26 Sep 2023
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://acpinternist.org/archives/2023/10/latest-updates-on-acps-priorities-initiatives.htm
1 Oct 2023
‘Night owls' more likely to have unhealthy lifestyles, higher diabetes risk
In a retrospective cohort study, people with an evening chronotype were more likely to smoke, sleep poorly, and be physically inactive and had a 72% higher risk for diabetes than those with a morning chronotype.
https://acpinternist.org/weekly/archives/2023/09/12/2.htm
12 Sep 2023
Oral drug for postpartum depression approved
This column reviews recent recalls, alerts, and approvals.
https://acpinternist.org/archives/2023/10/oral-drug-for-postpartum-depression-approved.htm
1 Oct 2023
SGLT-2 inhibitors reduced gout flares in patients with diabetes, gout
New users of sodium-glucose cotransporter-2 (SGLT-2) inhibitors had about half the risk of an ED visit or hospitalization for a gout flare as matched patients taking dipeptidyl peptidase-4 inhibitors, a cohort analysis found.
https://acpinternist.org/weekly/archives/2023/07/25/1.htm
25 Jul 2023
Large review compares benefits, harms of drugs to treat type 2 diabetes
High-certainty evidence indicated that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists reduce all-cause death, while finerenone probably also reduced mortality based on moderate-certainty evidence.
https://acpinternist.org/weekly/archives/2023/04/18/4.htm
18 Apr 2023
Overweight, obesity poorly managed in type 1 diabetes
While U.S. adults with type 1 diabetes have rates of overweight and obesity virtually identical to those in the general adult population, only about 50% received lifestyle recommendations for weight management from clinicians or tried lifestyle modifications.
https://acpinternist.org/weekly/archives/2023/02/14/4.htm
14 Feb 2023
Nocturnal hypoglycemia underdiagnosed in older patients on insulin for type 2 diabetes
An industry-funded study of patients ages 75 years and older who were taking insulin for type 2 diabetes found that almost two-thirds (65.2%) experienced nocturnal hypoglycemia during a 28-day study period.
https://acpinternist.org/weekly/archives/2023/04/04/1.htm
4 Apr 2023